The discovery of AZD9164, a novel muscarinic M3 antagonist.

@article{Mete2011TheDO,
  title={The discovery of AZD9164, a novel muscarinic M3 antagonist.},
  author={A. Mete and K. Bowers and E. Chevalier and D. Donald and H. Edwards and K. J. Escott and R. Ford and K. Grime and Ian Millichip and B. Teobald and V. Russell},
  journal={Bioorganic & medicinal chemistry letters},
  year={2011},
  volume={21 24},
  pages={
          7440-6
        }
}
  • A. Mete, K. Bowers, +8 authors V. Russell
  • Published 2011
  • Chemistry, Medicine
  • Bioorganic & medicinal chemistry letters
  • The optimization of a new series of muscarinic M(3) antagonists is described, leading to the identification of AZD9164 which was progressed into the clinic for evaluation of its potential as a treatment for COPD. 
    15 Citations

    Topics from this paper

    The design of a novel series of muscarinic receptor antagonists leading to AZD8683, a potential inhaled treatment for COPD.
    • 8
    Emerging muscarinic receptor antagonists for the treatment of asthma
    Long-Acting Muscarinic Antagonists Under Investigational to Treat Chronic Obstructive Pulmonary Disease
    • PDF
    Novel anti-cholinergics in COPD.
    • 10
    Long-acting muscarinic antagonists
    • A. Melani
    • Medicine
    • Expert review of clinical pharmacology
    • 2015
    • 38

    References

    SHOWING 1-10 OF 12 REFERENCES
    Long-acting muscarinic antagonists for the treatment of chronic obstructive pulmonary disease
    • D. Laine
    • Medicine
    • Expert review of clinical pharmacology
    • 2010
    • 10
    Medicinal chemistry and therapeutic potential of muscarinic M3 antagonists
    • 33
    Muscarinic receptor subtype pharmacology and physiology.
    • R. Eglen
    • Biology, Medicine
    • Progress in medicinal chemistry
    • 2005
    • 176
    Characterization of Aclidinium Bromide, a Novel Inhaled Muscarinic Antagonist, with Long Duration of Action and a Favorable Pharmacological Profile
    • 118
    • PDF
    Potential for long-acting muscarinic antagonists in chronic obstructive pulmonary disease
    • G. Joos
    • Medicine
    • Expert opinion on investigational drugs
    • 2010
    • 20